EMA visited Leiden Bio Science Park to explore how regulatory tools can better support early-stage innovation. The visit connected EMA representatives with local leaders across academia, investment, and biotech development for a forward-looking exchange on speeding therapies to patients.

A joint effort between Leiden University's Professor Ubbink's lab and ZoBio's Assay Development and Screening team has advanced fragment-based drug...

Leyden Labs has secured €20 million in financing from the European Investment Bank (EIB), supported by HERA Invest under the EU’s InvestEU...

Researchers at Leiden University Medical Center (LUMC), in collaboration with Erasmus MC and the Oncode Institute, have developed a novel vaccine...

The May TechTalk at Leiden Bio Science Park focused on women’s health as a key driver of innovation, featuring expert insights on cardiology, diagnostics, early development, and maternal care. The event sparked lasting conversations and a shared call for more inclusive, tailored healthcare solutions.

Leiden University Medical Center (LUMC) has achieved a national milestone by treating the first Dutch patient with an autoimmune disease using CAR-T...

The latest Life Sciences Café at Leiden Bio Science Park highlighted AI in mental health, animal-free dairy innovation, and early liver disease detection. Co-hosted with hollandbio, the event showcased pioneering startups and celebrated the strength of the local life sciences community.

TNO and FAST (Financiering en Acceleratie voor Therapieontwikkeling) have launched a strategic collaboration to accelerate the development of...

Leiden University Medical Center (LUMC) has successfully implemented artificial intelligence (AI) to optimize radiotherapy planning for patients...